Centre hospitalier de gordes
Gordes - 100 route de mursCabinet du pr vincent esnault
Gordes - place charles de gaulle
Gordes - 100 route de mursCabinet du pr vincent esnault
Gordes - place charles de gaulle
Présentation
ESNAULT Vincent est Néphrologue à Gordes, centre hospitalier de gordes est au 100 route de murs à Gordes dans le 84220.
ESNAULT Vincent est aussi disponible à d'autres adresses.
Tarifs et remboursements
Conventionnement
Secteur 1
Ce praticien applique des tarifs fixés par l'assurance maladie, sans dépassement d'honoraires
Tarifs
Consultation : 31,50 €*
*Médecin correspondant - sur avis de votre médecin traitant.
Carte vitale Le praticien prend la carte vitale
Moyens de paiement
Espèces, Chèques
Spécialités et Recommandations
- Calculs rénaux
- Syndrome néphrotique
- Exploration rénale
- Hypertension artérielle
- Insuffisance cardiaque
- Insuffisance rénale
- Maladie auto-immune
- Cardiologie et maladies vasculaires
Informations pratiques
Adresse
Pr ESNAULT Vincent
100 route de murs 84220 Gordes
Langue(s) parlée(s) anglais, français
Accès
Rez-de-chaussée, Entrée accessible, Parking payant
Accès handicapé Non renseigné
Horaires
Mardi : 08:30-13:00 14:00-19:00
Formation
- 1991 : Doctorat en sciences de la vie et de la santé - Université de Nantes
- 1987 : C.E.S. Néphrologie - Faculté de médecine de Nantes
- 1987 : C.E.S. Cardiologie - Faculté de médecine de Nantes
Parcours professionnel
- 2006 - 2025 Néphrologie-Dialyse-Transplantation : Professeur des universités-praticien hospitalier - Université Nice Sophia Antipolis - Nice
- 1992 - 2006 Néphrologie-Immunologie Clinique : Professeur des universités-praticien hospitalier - Université de Nantes - Nantes
Autres cabinets de consultation
Consultation dans 2 cabinets différents
Motifs de consultation
- Consultation de suivi de néphrologie
- Première consultation de néphrologie
Types d'actes
- APC 60 €
Praticiens au sein de la même structure
6 praticiens au sein de centre hospitalier de gordes
Publications
- Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature.
Gauci PA, Cremoni M, Delotte J, Vocila F, Esnault VLM, Seitz-Polski B, Teisseyre M.
Ren Fail. 2025, 47(1): 2481201.
Article - Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST).
P. Rossignol P... V. Esnault...L. Frimat.
Lancet 2025,406:705-718.
Article - Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.
Teisseyre M, …, Esnault VLM, Benito S, Seitz-Polski B.
Clin Kidney J. 2025, 18(5): sfaf113.
Article - Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.
Allinovi M, …, Esnault VLM, …, Seitz-Polski B.
Kidney Int Rep. 2025, 10(8): 2621-2629.
Article
Est-ce que Pr ESNAULT Vincent, Néphrologue, accepte la carte vitale ?
Prise en charge par Pr ESNAULT Vincent de la carte vitale : carte vitale acceptée.
Est-ce que Pr ESNAULT Vincent, Néphrologue, est conventionné ?
Votre Néphrologue, Pr ESNAULT Vincent, est conventionné secteur 1.
Quels sont les actes proposés par Pr ESNAULT Vincent, Néphrologue ?
Quels sont les compétences professionnelles de Pr ESNAULT Vincent, Néphrologue ?
Les compétences de Pr ESNAULT Vincent, Néphrologue, sont :
- Calculs rénaux
- Syndrome néphrotique
- Exploration rénale
- Hypertension artérielle
- Insuffisance cardiaque
- Insuffisance rénale
- Maladie auto-immune
- Cardiologie et maladies vasculaires
Quelles sont les langues parlées par Pr ESNAULT Vincent, Néphrologue ?
Les langues parlées par Pr ESNAULT Vincent, Néphrologue, sont : anglais, français.
Quels sont les moyens de paiement acceptés par Pr ESNAULT Vincent, Néphrologue ?
Pr ESNAULT Vincent, Néphrologue, accepte : Espèces, Chèques.
Quelles sont les formations suivies par Pr ESNAULT Vincent, Néphrologue ?
Les formations suivies par Pr ESNAULT Vincent, Néphrologue, sont :
- 1991 - Doctorat en sciences de la vie et de la santé - Université de Nantes
- 1987 - C.E.S. Néphrologie - Faculté de médecine de Nantes
- 1987 - C.E.S. Cardiologie - Faculté de médecine de Nantes
Quel est le parcours professionnel de Pr ESNAULT Vincent, Néphrologue ?
Le parcours professionnel de Pr ESNAULT Vincent, Néphrologue, est le suivant :
- 2006 - 2025 Néphrologie-Dialyse-Transplantation - Professeur des universités-praticien hospitalier - Université Nice Sophia Antipolis - Nice
- 1992 - 2006 Néphrologie-Immunologie Clinique - Professeur des universités-praticien hospitalier - Université de Nantes - Nantes
Quelles sont les publications de Pr ESNAULT Vincent, Néphrologue ?
Les publications de Pr ESNAULT Vincent, Néphrologue, sont les suivantes :
- Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature.
Gauci PA, Cremoni M, Delotte J, Vocila F, Esnault VLM, Seitz-Polski B, Teisseyre M.
Ren Fail. 2025, 47(1): 2481201.
Article - Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST).
P. Rossignol P... V. Esnault...L. Frimat.
Lancet 2025,406:705-718.
Article - Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.
Teisseyre M, …, Esnault VLM, Benito S, Seitz-Polski B.
Clin Kidney J. 2025, 18(5): sfaf113.
Article - Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.
Allinovi M, …, Esnault VLM, …, Seitz-Polski B.
Kidney Int Rep. 2025, 10(8): 2621-2629.
Article - Renoprotective treatments: renin-angiotensin-aldosterone system blockade and beyond.
Esnault V.
Rev Prat. 2024, 74(6): s19-s22.
Article - Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies.
Teisseyre M, …, Esnault VLM, …, Seitz-Polski B.
Kidney Int Rep. 2024, 10(3): 753-761.
Article - Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation.
Cremoni M, …, Esnault V, Sicard A, Seitz-Polski B.
Kidney Int Rep. 2024, 9(12): 3427-3438.
Article - Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy.
Teisseyre M, …, Esnault VLM, Seitz-Polski B.
Clin J Am Soc Nephrol. 2023, 18(6): 785-787.
Article - Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN.
Meuleman MS, …, Esnault V, …, Chauvet S.
Clin J Am Soc Nephrol. 2023, 18(11): 1435-1445.
Article - Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.
Destere A, …, Esnault VLM, Benito S, Drici MD, Seitz-Polski B.
Kidney Int Rep. 2023, 9(1): 134-144.
Article - Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.
Teisseyre M, …, Esnault VLM, Barrière J, Brglez V, Seitz-Polski B.
Nephrol Dial Transplant. 2023, 38(1): 249-251.
Article - Toxic Occupational Exposures and Membranous Nephropathy.
Cremoni M, Agbekodo S, Teisseyre M, Zorzi K, Brglez V, Benzaken S, Esnault V, Planchard JH, Seitz-Polski B.
Clin J Am Soc Nephrol. 2022, 17(11): 1609-1619.
Article - Risk factors associated with immune checkpoint inhibitor-induced acute kidney injury compared with other immune-related adverse events: a case-control study.
Gérard AO, …, Esnault VLM, …, Drici MD.
Clin Kidney J. 2022, 15(10): 1881-1887.
Article - New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review.
Gérard AO, Laurain A, Sicard A, Merino D, Pathak A, Drici MD, Favre G, Esnault VLM.
Pharmaceutics. 2022, 14(8): 1569.
Article - Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.
Cremoni M, …, Esnault VLM, Dellamonica J, Carles M, Barrière J, Ticchioni M, Brglez V, Seitz-Polski B.
Front Immunol. 2022, 13: 953502
Article - Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients.
Cremoni M, …, Esnault V, Le Quintrec M, Caillard S, Glaichenhaus N, Sicard A.
Viruses. 2022, 14(3): 542.
Article - Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome.
Meuleman MS, …, Esnault V, …, Mellerio H.
J Nephrol. 2022, 35(4): 1123-1134.
Article - Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety Database.
Gérard AO, …, Esnault VLM, Sicard A, Drici MD.
Kidney Int Rep. 2022, 7(7): 1699-1702.
Article - Cardiovascular Events with Finerenone in CKD and Diabetes.
Gérard AO, Laurain A, Esnault VLM.
N Engl J Med. 2022, 386(16): e43.
Article - Air pollution exposure induces a decrease in type II interferon response: A paired cohort study.
Allouche J, …, Esnault V, Levraut M, Oppo S, Jacquinot M, Armengaud A, Pradier C, Bailly L, Seitz-Polski B.
EBioMedicine. 2022, 85: 104291.
Article - Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.
Teisseyre M, …, Esnault VLM, Brglez V, Seitz-Polski B.
Front Immunol. 2022, 13: 859419.
Article - Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?
Gérard AO, …, Esnault VLM.
Diabetes Care. 2022, 45(10): e148-e149.
Article - Visceral fat is associated to the severity of COVID-19.
G. Favre, K. Legueult, C. Pradier, MD, C. Raffaelli, C. Ichai, A. Iannelli, A. Redheuil, O. Lucidarme, V.L.M. Esnault.
Metabolism 2021, 115: 154440.
Article - Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients.
Massa F, … Esnault VLM, …, Sicard A.
EBioMedicine. 2021, 73: 103679.
Article - Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.
Teisseyre M, …, Esnault V, Brglez V, Seitz-Polski B.
Front Immunol. 2021, 12: 738788.
Article - Remdesivir and acute renal failure: a potential safety signal from disproportionality analysis of the WHO safety database.
A.O. Gérard, …, V.L.M. Esnault, M.D. Drici.
Clin Pharmacol Ther. 2021, 109: 1021-1024.
Article - Regulation of monocytes-macrophages by the renin-angiotensin system in diabetic nephropathy: state of the art and results from a pilot study.
C. Moratal, …, V.L.M. Esnault, …, G. Favre.
Int J Mol Sci. 2021, 22(11): 6009.
Article - Proteinuria as a biomarker for COVID-19 severity.
H. Ouahmi, J. …, V.L.M. Esnault, …, S. Boyer-Suavet.
Front Physiol. 2021, 12: 611772.
Article - Immune checkpoint inhibitors-induced nephropathy: a French national survey.
Gérard AO, …, Esnault VLM, Drici MD; French Network of Pharmacovigilance Centers.
Cancer Immunol Immunother. 2021, 70(11): 3357-3364.
Article - Humoral and cellular response of frontline health care workers infected by SARS-CoV-2 in Nice, France: a prospective single-center cohort study.
M. Cremoni, …, V.L.M Esnault, V. Brglez, B. Seitz-Polski.
Front Med (Lausanne). 2021, 7: 608804.
Article - Extracellular fluid volume: A suitable indexation variable to assess impact of bariatric surgery on glomerular filtration rate in patients with chronic kidney disease.
Grangeon-Chapon C, …, Esnault VLM, …, Favre GA.
PLoS One. 2021, 16(8): e0256234
Article - Cohort study: "Outcomes of kidney transplantation in patients with prosthetic heart valves".
Ouahmi H, …, Esnault V, Merville P, Legendre C, Giral M, Sicard A.
Transpl Int. 2021, 34(11): 2297-2304.
Article - Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
A.O. Gérard, G. Favre, V.L.M. Esnault.
N Eng J Med. 2021, 384: 386-7.
Article - Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients.
A.O. Gérard, …, V.L.M. Esnault, T. ..., B. Seitz-PolskiB.
J Immunother Cancer. 2021, 9(6): e002512
Article - Analysis and management of rituximab resistance in PLA2R1-associated membranous nephropathy.
M. Teisseyre, S. Boyer-Suavet, M. Crémoni, V. Brglez, V.L.M. Esnault, B. Seitz-Polski.
Kidney Int Rep. 2021, 6: 1183-1188.
Article - Th17-immune response in patients with membranous nephropathy is associated with thrombosis and relapses.
M. Cremoni, …, V.L.M. Esnault, B. Seitz-Polski.
Front Immunol. 2020, 11: 574997.
Article - QT interval prolongation under hydroxychloroquine/azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection.
S.S. Bun, P. …, V.L.M. Esnault, S-S. Bun, E. Ferrari.
Clin Pharmacol Ther. 2020, 108: 1090-1097.
Article - Personalized medicine for PLA2R1-related membranous nephropathy: a multicenter randomized control trial.
V. Brglez, S. Boyer-Suavet, K. Zorzi, C. Fernandez, E. Fontas, V.L.M. Esnault, B. Seitz-Polski.
Front Med (Lausanne). 2020, 7: 412.
Article - Obesity and COVID-19: ACE 2, the missing tile.
A. Iannelli, G. Favre, S. Frey, V.L.M. Esnault, J. Gugenheim, S. Bouam, L. Schiavo, A. Tran, M. Alifano.
Obes Surg. 2020, 30: 4615-4617.
Article - Neutralizing anti-rituximab antibodies and relapse in membranous nephropathy treated with rituximab.
S. Boyer-Suavet, …, V.L.M. Esnault, B. Seitz-Polski.
Front. Immunol. 2020, 10: 3069.
Article - The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again.
P. Hofman, N. …, V.L.M. Esnault, …, L. Yvan-Charvet.
Cancers (Basel). 2019, 11: E250.
Article - Rituximab bioavailability in primary membranous nephropathy.
S. Boyer-Suavet, M. Andreani, M. Cremoni, V. Brglez, S. Benzaken, G. Bernard, P. Nachman, V.L.M. Esnault*, Barbara Seitz-Polski* (* co-last author).
Nephrol. Dial. Transplant. 2019, 34: 1423-5
Article - Osmotic stress and mortality in elderly patients with kidney failure: a retrospective study.
C. Grangeon-Chapon, M. Dodoi, V.L.M. Esnault, G. Favre.
Clin. Interv. Aging. 2019, 14: 225-9.
Article - Monitoring of CMV-specific cell-mediated immunity in kidney transplant recipients with a high risk of CMV disease (D+/R-): a case series.
M. Andreani, L. …, V.L.M. Esnault, Seitz-Polski B.
Transplant. Proc. 2019, 1345: 30314-8.
Article - High dose Rituximab and early remission in PLA2R1-related membranous nephropathy.
B. Seitz-Polski, …, V.L.M. Esnault.
Clin. J. Am. Soc. Nephrol. 2019, 14: 1173-82.
Article - Functional immune assay using interferon-gamma could predict infectious events in end-stage kidney disease.
S. Boyer-Suavet, …, V.L.M. Esnault, B. Seitz-Polski.
Clin. Chim. Acta 2019, 502: 287-292.
Article - Anti-PLA2R1 antibodies containing sera induce in vitro cytotoxicity mediated by complement activation.
M. Lateb, …, V.L.M. Esnault, G. Lambeau, B. Seitz-Polski.
J. Immunol. Res. 2019, 2019: 1324804.
Article - Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study.
R. Anty, …, V.L.M. Esnault, …, JC. Duclos-Vallée.
Aliment. Pharmacol. Ther. 2018, 47: 1682-9.
Article - Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy.
B. Seitz-Polski, …, V.L.M. Esnault, G. Lambeau, P. Ronco.
J. Am. Soc. Nephrol. 2018, 29: 401-8.
Article - Longitudinal assessment of renal function in native kidney after bariatric surgery.
G. Favre, L. Schiavo, S. Lemoine, V.L.M. Esnault, A. Iannelli.
Surg. Obes. Relat. Dis. 2018, 14: 1411-8.
Article - Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass.
G. Favre, C. Grangeon-Chapon, C. Raffaelli, F. François-Chalmin, A. Iannelli, V.L.M. Esnault.
PLoS One. 2017, 12: e0175561.
Article - Glomérulonéphrite extramembraneuse: physiopathologie et histoire naturelle.
B. Seitz-Polski, G. Lambeau, V.L.M. Esnault.
Nephrol. Ther. 2017, 13 Suppl 1: S75-S81.
Article - Determinants associated with the correction of glomerular hyper-filtration one year after bariatric surgery.
G.A. Favre, …, V.L.M. Esnault.
Surg. Obes. Relat. Dis. 2017, 13: 1760-6.
Article - Vitamin E-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis: a multi-center, randomized, cross-over trial.
M. Shariful Islam, …, V.L.M. Esnault.
Am. J. Kidney Dis. 2016, 68: 752-62
Article - Epitope spreading of autoantibody response to PLA2R1 associates with poor prognosis in membranous nephropathy.
B. Seitz-Polski, …, V.L.M. Esnault*, G. Lambeau* (* co-last author).
J. Am. Soc. Nephrol. 2016, 27: 1517-33
Article - Modulation of glucose metabolism by the renin angiotensin-aldosterone system.
G.A. Favre, V.L.M. Esnault, E. Van Obberghen.
Am. J. Physiol. Endocrinol. Metab. 2015, 308: E435-E449.
Article - Improvement of Kidney Function Following Bariatric Surgery: Hope or Illusion?
G. Favre, A.S. Schneck, R. Anty, V.L.M. Esnault, A. Iannelli.
Obes. Surg. 2015, 25: 1947-9
Article - Cross-reactivity of anti-PLA2R1 antibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs.
B. Seitz-Polski, …, V.L.M. Esnault*, G. Lambeau* (* co-last author).
Biochimie 2015, 118: 104-15
Article - Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
B. Seitz-Polski, …, V.L.M. Esnault.
Nephrol. Dial. Transplant. 2014, 29: 23
Article - Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in type 2 diabetics with overt nephropathy.
O. Moranne, …, V.L.M. Esnault.
Clin. J. Am. Soc. Nephrol. 2013, 8: 1694-701
Article - Diuretic up-titration with half-dose combined ACEI+ARB better decrease proteinuria than combined ACEI+ARB up-titration.
V.L.M. Esnault, A. Ekhlas, J-M. Nguyen, O. Moranne.
Nephrol. Dial. Transplant. 2010, 25: 2218-24
Article - Randomized, double-blind, placebo-controlled, 3-year study comparing the effect of amolodipine and enalapril on renal function in adults with non-diabetic nephropathies.
V.L.M. Esnault, et al.
Clin. Ther. 2008, 30: 482-98
Article - Ralentissement de la progression de la maladie rénale chronique: actualités.
V.L.M. Esnault.
Néphrol. Thér. 2007, 3(suppl3): S210-7.
Article - Home blood pressure during normal pregnancy.
T. Denolle, J-C. Daniel, C. Calvez, J-N. Ottavioli, V.L.M. Esnault, D. Herpin.
Am. J. Hypertens. 2005, 18: 1178-1180.
Article - Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents.
V.L.M. Esnault, A. Ekhlas, C. Delcroix, M-G. Moutel, J-M. Nguyen.
J. Am. Soc. Nephrol. 2005, 16: 474-481
Article - High dose furosemide for established ARF: a prospective randomized, double-blind; placebo-controlled multicenter trail.
F. Cantarovich, B. Rangoonwala, H. Lorenz, M. Verho, V.L.M. Esnault.
Am. J. Kidney Dis. 2004, 44: 402-409
Article - Difference in antigenic determinant profiles between human and rat myeloperoxidase.
Y.C. Patry, P.H. Nachman, M.A.P. Audrain, R.J. Falk, K. Meflah, V.L.M. Esnault.
Clin. Exp. Immunol. 2003, 132: 505-508
Article - Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
V.L.M. Esnault.
N. Engl. J. Med. 2003, 349:91
Article - Radiocontrast media-induced nephrotoxicity in patients with renal failure: rational for a new double-blind, prospective, randomized trial testing calcium channel antagonists.
V.L.M. Esnault.
Nephrol. Dial. Transplant. 2002, 17: 1362-1364.
Article - Complications abdominales de la dialyse péritonéale.
F. Villemain, JP. Ryckelynck, T. Lobbedez, A. Testa, W. El Haggan, V.L.M. Esnault, B Hurault de Ligny.
Néphrologie 2002, 23: 237-243.
Article - Apoptosis: the central actor in the three hits that trigger anti-neutrophil cytoplasmic antibody-related systemic vasculitis.
V.L.M. Esnault.
Nephrol. Dial. Transplant. 2002, 17: 1725-1728.
Article - Rats injected with syngenic apoptotic neutrophils develop antineutrophil cytoplasmic antibodies.
Y.C. Patry, …, V.L.M. Esnault.
J. Am. Soc. Nephrol. 2001, 12: 1764-1768.
Article - Atteintes rénales au cours des vascularites. Vascularites sans anticorps anti-cytoplasme des polynucléaires neutrophiles.
V.L.M. Esnault.
Presse Méd. 2001, 30: 1126-1129.
Article - Atteintes rénales au cours des vascularites. Vascularites avec anticorps anti-cytoplasme des polynucléaires neutrophiles (ACPN)
V.L.M. Esnault.
Presse Méd. 2001, 30: 1122-1125.
Article - Atteintes rénales au cours des vascularites. Les vascularites et leur classification.
V.L.M. Esnault.
Presse Méd. 2001, 30: 1119-1120.
Article - Analysis of anti-neutrophil cytoplasmic antibodies (ANCA) frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.
M.A.P. Audrain, …, V.L.M. Esnault.
Nephrol. Dial. Transplant. 2001, 16: 39-44.
Article - Renoprotective properties of angiotensin-converting enzyme inhibitors: proofs and limits?
V.L.M. Esnault.
Nephron 2000, 85: 183-184.
Article - Protéinurie : orientation diagnostique.
V.L.M. Esnault.
Rev. Prat. 2000, 50: 1383-1389.
Article - International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA).
J. Savige, D. Gillis, E. Benson, D. Davies, V.L.M. Esnault, R.J. Falk et al.
Am. J. Clin. Pathol. 1999, 111: 507-513.
Article - Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies.
V.L.M. Esnault, D.P. Besnier, A. Testa, P. Coville, P. Simon, J-F. Subra, M.A.P. Audrain.
J. Am. Soc. Nephrol. 1999, 10: 2014-2017.
Article - Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel disease.
C. Taddéi, …, V.L.M. Esnault.
Eur. J. Gastroenterol. Hepatol. 1999, 11: 1293-1298.
Article - Treatment of Graft-Versus-Host Disease (GvHD) by Extracorporeal Photochemotherapy (ECP): A pilot study
D.P. Besnier, …, V.L.M. Esnault.
Transplantation 1997, 64: 49-54.
Article - Recurrence of immunoglobulin A nephropathy with immunoglobulin A antineutrophil cytoplasmic antibodies following renal transplantation.
S.J. Martin, …, V.L.M. Esnault.
Am. J. Kidney Dis. 1997, 29: 125-131.
Article - Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone-marrow transplantation.
S.J. Martin, .., V.L.M. Esnault.
Bone Marrow Transplant. 1997, 20: 45-48.
Article - Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies.
M.A.P. Audrain, T.A.R. Baranger, N. Moguilevski, S.J. Martin, A. Devys, C.M. Lockwood, J.Y. Muller, V.L.M. Esnault.
Clin. Exp. Immunol. 1997, 107: 127-134.
Article - Alpha1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis.
V.L.M. Esnault, M.A.P. Audrain, Sesboue R.
Exp. Clin. Immunogenet. 1997, 14: 206-213.
Article - ANCA-positive vasculitis and alpha1-antitrypsin deficiency: Could free ANCA antigens released by neutrophils mediate vasculitic lesions?
V.L.M. Esnault.
Nephrol. Dial. Transplant. 1997, 12: 249-251.
Article - Rise in ANCA may not be related to relapse of vasculitides during Wegener’s granulomatosis complicated by bacterial infection.
J.H. Barrier, …, V.L.M. Esnault, F. Raffi.
Eur. J. Int. Med. 1995, 6: 199-201.
Article - Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification?
T.A.R. Baranger, M.A.P. Audrain, A. Testa, D. Besnier, L. Guillevin, V.L.M. Esnault.
Autoimmunity 1995, 20: 33-37.
Article - ANCA and anti-GBM antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis.
A.K. Short, V.L.M. Esnault, C.M. Lockwood.
Am. J. Kidney Dis. 1995, 26: 439-445.
Article - Syndrome néphritique aigu : physiopathologie, diagnostic.
V.L.M. Esnault.
Rev. Prat. 1994, 44: 1971-1975.
Article - Does truly "idiopathic" crescentic glomerulonephritis exist?
R. Angangco, S. Thiru, V.L.M. Esnault, A.K. Short, C.M. Lockwood, D.B.G. Oliveira.
Nephrol. Dial. Transplant. 1994, 9: 630-636.
Article - Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays.
V.L.M. Esnault, A.K. Short, M.A.P. Audrain, S.J. Jones, S.J. Martin, J.M. Skehel, C.M. Lockwood.
Kidney Int. 1994, 46: 153-160.
Article - Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura.
N. Ronda, V.L.M. Esnault, L. Layward, V. Sepe, A. Allen, J. Feehally, C.M. Lockwood.
Clin. Exp. Immunol. 1994, 95: 49-55.
Article - Absence of antineutrophil cytoplasm antibodies in giant cell arteritis.
T.A.R. Baranger, M. Audrain, A. Castagné, J.H. Barrier, V.L.M. Esnault.
J. Rheumatol. 1994, 21: 871-873.
Article - Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis
V.L.M. Esnault, A. Testa, D.R.W. Jayne, J-P. Soulillou, J. Guenel.
Nephron 1993, 65: 180-184.
Article - Association of ANCA isotype and affinity with disease expression.
V.L.M. Esnault, N. Ronda, D.R.W. Jayne, C.M. Lockwood.
J. Autoimmun. 1993, 6: 197-205.
Article - Animal models of systemic vasculitis.
P.W. Mathieson, F.J. Qasim, V.L.M. Esnault, D.B.G. Oliveira.
J. Autoimmun. 1993, 6: 251-264.
Article - Alpha1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis.
V.L.M. Esnault, A. Testa, M. Audrain, C. Rogé, M. Hamidou, J.H. Barrier, R. Sesboüé, J.P. Martin, P. Lesavre.
Kidney Int. 1993, 43: 1329-1332.
Article - Rares spécificités et mécanismes d'action des ANCA.
V.L.M. Esnault, C.M. Lockwood.
Néphrologie 1992, 13: 275-277.
Article - Pulmonary-renal syndrome in association with anti-GBM and IgM ANCA.
D.M. Thomas, R. Moore, K. Donovan, D.C. Wheeler, V.L.M. Esnault, C.M. Lockwood.
Lancet 1992, 339: 1304.
Article - Association of IgM with IgG ANCA in patients presenting with pulmonary haemorrhage.
V.L.M. Esnault, B. Soleimani, M.T. Keogan, A.A. Brownlee, D.R.W. Jayne, C.M. Lockwood.
Kidney Int. 1992, 41: 1304-1310
Article - Anticorps anti-constituants cytoplasmiques des polynucléaires. De la biologie à la clinique.
V.L.M. Esnault.
Ann. Med. Interne 1992, 143: 399-400.
Article - Anti-neutrophil cytoplasm antibodies (ANCA) of IgA class correlate with disease activity in adult Henoch-Schönlein purpura.
G. Shaw, N. Ronda, J.S. Bevan, V.L.M. Esnault, D.F.R. Griffiths, A. Rees.
Nephrol. Dial. Transplant. 1992, 7: 1238-1241.
Article - Anti-myeloperoxidase antibodies and necrotizing vasculitis in Brown Norway rats treated with mercuric chloride.
V.L.M. Esnault, P.W. Mathieson, S. Thiru, D.B.G. Oliveira, C.M. Lockwood.
Lab. Invest. 1992, 67: 114-120
Article - Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies.
M.T. Keogan, V.L.M. Esnault, A.J. Green, C.M. Lockwood, D.L. Brown.
Clin. Exp. Immunol. 1992, 90: 228-234.
Article - IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up.
V.L.M. Esnault, D.R.W. Jayne, A.P. Weetman, C.M. Lockwood.
Immunology 1991, 74: 714-718.
Article - Captopril but not Acebutolol, Prazosin or Indomethacin decreases post-exercise proteinuria.
V.L.M. Esnault, M. Potiron/Josse, A. Testa, J. Ginet, D. Le Carrer, J. Guenel.
Nephron 1991, 58: 437-442
Article - Major muscle calcifications of the neck after non-traumatic rhabdomyolysis with acute renal failure.
V.L.M. Esnault, A. Testa, B. Dupas, J. Guenel.
Nephrol. Dial. Transplant. 1990, 5: 461-463.
Article - Effect of protein A immunoadsorption on panel lymphocyte reactivity in hyperimmunizated patients awaiting kidney graft.
V.L.M. Esnault, J.D. Bignon, A. Testa, J.L. Preud'homme, A. Vergracht, J.P. Soulillou.
Transplantation 1990, 50: 449-453
Article - Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies.
V.L.M. Esnault, D.R.W. Jayne, M.T. Keogan, A.A. Brownlee, A. Testa, D. Lecarrer, D.L. Brown, C.M. Lockwood.
J. Clin. Lab. Immunol. 1990, 32: 153-159.
Article - Insuffisance rénale aiguë réversible avec oxalose tubulaire. Rôle possible de facteurs nutritionnels.
V.L.M. Esnault, C. Delcroix, P. Dubigeon, J. Guenel.
Néphrologie 1988, 9: 277-280.
Article
Où consulte Pr ESNAULT Vincent, Néphrologue ?
Nombre de lieux de consultation de votre praticien : 2
Quelle est la spécialité de Pr ESNAULT Vincent ?
La spécialité de Pr ESNAULT Vincent est Néphrologue
Quels sont les motifs de consultation de Pr ESNAULT Vincent, Néphrologue ?
Les motifs de consultation de Pr ESNAULT Vincent, Néphrologue, sont :
- Consultation de suivi de néphrologie
- Première consultation de néphrologie
Combien de praticiens exercent sur le lieu d’exercice de Pr ESNAULT Vincent ?
6 praticiens exercent sur le lieu d’exercice de Pr ESNAULT Vincent au 100 route de murs 84220 Gordes
Quels sont les praticiens pratiquant dans la même structure que Pr ESNAULT Vincent ?
Les praticiens pratiquant dans la même structure que Pr ESNAULT Vincent (centre hospitalier de gordes) au 100 route de murs 84220 Gordes sont :
Quels sont les modalités d’accès au lieu d’exercice de Pr ESNAULT Vincent ?
Rez-de-chaussée, Entrée accessible, Parking payant
Quels sont les honoraires pratiqués par Pr ESNAULT Vincent, Néphrologue ?
Les honoraires pratiqués par Pr ESNAULT Vincent, Néphrologue, sont :
Consultation : 31,50 €*
*Médecin correspondant - sur avis de votre médecin traitant.
Consultation : 31,50 €*
*Médecin correspondant - sur avis de votre médecin traitant.
Résultats de votre recherche
Médecin non disponible sur lemedecin.fr
Veuillez le contacter par téléphone
Téléconsultation avec un autre médecin si votre médecin n’est pas disponible
